A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL). (Q33924570)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL). |
scientific article |
Statements
1 reference
A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL). (English)
1 reference
Stephan A Grupp
1 reference
Michael A Pulsipher
1 reference
Donna A Wall
1 reference
Michael Grimley
1 reference
Rakesh K Goyal
1 reference
Kenneth M Boucher
1 reference
Patricia Hankins
1 reference
Nancy Bunin
1 reference
10 September 2009
1 reference
1 reference
147
1 reference
691-699
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference